Trial · NCT03280030
Adverse event totals21
The totals the trial posted for each group.
1 to 20 of 21
Download this page as JSON| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Midostaurin: Part 1 (Japan Only) (On-treatment) | 1 | 5 |
| Total, all-cause mortality | Midostaurin: Part 2 (On-treatment) | 3 | 30 |
| Total, all-cause mortality | Placebo Part 2 (On-treatment) | 1 | 31 |
| Total, all-cause mortality | Midostaurin: Part 1 (Japan Only) (Post-treatment Survival Follow-up) | 2 | 4 |
| Total, all-cause mortality | Midostaurin: Part 2 (Post-treatment Survival Follow-up) | 7 | 27 |
| Total, all-cause mortality | Placebo: Part 2 (Post-treatment Survival Follow-up) | 6 | 30 |
| Total, all-cause mortality | Other Participants | 7 | 7 |
| Total, other adverse events | Midostaurin: Part 1 (Japan Only) (On-treatment) | 5 | 5 |
| Total, other adverse events | Midostaurin: Part 2 (On-treatment) | 30 | 30 |
| Total, other adverse events | Placebo Part 2 (On-treatment) | 31 | 31 |
| Total, other adverse events | Midostaurin: Part 1 (Japan Only) (Post-treatment Survival Follow-up) | 0 | 0 |
| Total, other adverse events | Midostaurin: Part 2 (Post-treatment Survival Follow-up) | 0 | 0 |
| Total, other adverse events | Placebo: Part 2 (Post-treatment Survival Follow-up) | 0 | 0 |
| Total, other adverse events | Other Participants | 0 | 0 |
| Total, serious adverse events | Midostaurin: Part 1 (Japan Only) (On-treatment) | 2 | 5 |
| Total, serious adverse events | Midostaurin: Part 2 (On-treatment) | 12 | 30 |
| Total, serious adverse events | Placebo Part 2 (On-treatment) | 10 | 31 |
| Total, serious adverse events | Midostaurin: Part 1 (Japan Only) (Post-treatment Survival Follow-up) | 0 | 0 |
| Total, serious adverse events | Midostaurin: Part 2 (Post-treatment Survival Follow-up) | 0 | 0 |
| Total, serious adverse events | Placebo: Part 2 (Post-treatment Survival Follow-up) | 0 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03280030/event-totals